Stay updated on Pembrolizumab in Relapsed Mediastinal Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Relapsed Mediastinal Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Relapsed Mediastinal Lymphoma Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    A new site Revision: v3.4.2 appears, and the previous government funding notice (and Revision: v3.4.1) has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T12:33:22.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A site-wide notice about government funding lapse and NIH Clinical Center status was added, and the system revision updated to v3.4.1 (replacing v3.4.0).
    Difference
    0.4%
    Check dated 2026-02-04T06:54:16.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Added access to the Study Protocol and Statistical Analysis Plan PDF, IPD sharing information and URLs, and Merck-related resources, and introduced glossary visibility with updated metadata.
    Difference
    51%
    Check dated 2026-01-28T04:48:01.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Minor update: Revision: v3.3.4 was added and Revision: v3.3.3 was removed on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T01:56:07.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Footer updates show Revision: v3.3.3 and removal of the HHS Vulnerability Disclosure; these are minor site maintenance changes and do not affect the study content, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T10:25:48.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    Revision update shows v3.3.2 replacing v3.3.1 with no visible changes to the study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T17:41:37.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Relapsed Mediastinal Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Relapsed Mediastinal Lymphoma Clinical Trial page.